GH
NasdaqGUARDANT HEALTH, INC.
Healthcare · Services-Medical Laboratories
Research view
Fundamentals · SEC EDGAR · FY 2025-12-31
Revenue & Earnings — fiscal year
$373.7M
2021
$449.5M
2022
$563.9M
2023
$739.0M
2024
$982.0M
2025
Snapshot
SEC EDGAR · FY 2025-12-31Revenue$982.0M
Net Income$-416.3M
Gross Profit—
Oper Income$-437.2M
EPS (dil)$-3.32
Rev/sh$7.41
FCF/sh$-1.76
Book/sh$-0.75
Gross M—
Oper M-44.5%
Profit M-42.4%
FCF M-23.7%
ROE419.2%
ROA-20.7%
ROIC-47.6%
R&D/Rev37.1%
Rev Y/Y32.9%
Rev 3Y CAGR29.8%
EPS Y/Y6.7%
EPS 3Y CAGR—
FCF 3Y CAGR—
Payout—
Div/sh—
Shs Chg Y/Y+2.1%
Current Ratio4.84
Quick Ratio4.56
Debt/Eq-15.14
Int Coverage-112.2×
Net Debt$1.0B
Total Debt$1.5B
Cash & Eq$489.4M
Total Assets$2.0B
Oper CF$-184.8M
Capex$48.3M
Free CF$-233.1M
Buybacks$45.0M
Equity$-99.3M
Liabilities$2.1B
Shs Outstand0.13B
SectorHealthcare
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 5 FY| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $373.7M | $449.5M | $563.9M | $739.0M | $982.0M |
| Gross Profit | — | — | — | — | — |
| Operating Income | $-411.0M | $-544.4M | $-564.7M | $-443.6M | $-437.2M |
| Net Income | $-384.8M | $-654.6M | $-479.4M | $-436.4M | $-416.3M |
| Diluted EPS | $-4.00 | $-6.41 | $-4.28 | $-3.56 | $-3.32 |
| Operating Cash Flow | $-209.0M | $-309.5M | $-325.0M | $-239.9M | $-184.8M |
| Free Cash Flow | $-284.1M | $-386.9M | $-345.5M | $-274.9M | $-233.1M |
COMMUNITY · $GH0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.